CVS Health reported third-quarterly earnings of $1.84 per share on Wednesday, which beat the analyst consensus estimate of $1.77 by 3.95%. This is a 6.36% increase over earnings of $1.73 per share from the same period last year.

The company reported quarterly sales of $64.81 billion, which beat the analyst consensus estimate of $63 billion by 2.87%. This is a 37.11% increase over sales of $47.269 billion the same period last year.

CVS Health raised fiscal year 2019 EPS from $6.89-$7 to $6.97-$7.05 versus the $6.98 estimate and has cuts operating income guidance from $11.82 billion – $12.02 billion to $11.77 billion – $11.95 billion.

“Our third-quarter results build on the positive momentum we have seen across the company since the beginning of the year. All of our core businesses performed in line with or above expectations, reflecting strong operational execution,” CEO Larry Merlo said in a statement.

“As we approach the first anniversary of the Aetna acquisition, we are increasingly confident in the strength of our broad and differentiated assets as a combined company and our ability to deliver compelling value to our customers and the communities we serve,” adds Merlo.

CVS Health shares were trading up 2.42% at $68.95 in Wednesday’s pre-market session. The stock has a 52-week high of $82.15 and a 52-week low of $51.72.

This story originally appeared on

© 2019 Benzinga does not provide investment advice. All rights reserved.

Jessica Rinaldi/The Boston Globe via Getty Images

Leave a Reply

Your email address will not be published. Required fields are marked *